Around 630,000 people died from AIDS-related illnesses worldwide in 2024. That number, while still staggering, represents a 70% drop from the peak of 2.1 million deaths in 2004. The decline is largely driven by the global expansion of antiretroviral therapy, but hundreds of thousands of deaths each year remain preventable.
How the Numbers Have Changed Over Time
The mid-2000s marked the worst of the AIDS crisis in terms of annual mortality. In 2004, an estimated 2.1 million people died from the disease in a single year. By 2010, that figure had fallen to 1.4 million as treatment programs expanded across the hardest-hit regions. The decline continued steadily, reaching 630,000 deaths in 2024.
That trajectory tracks closely with the rollout of antiretroviral therapy, which suppresses the virus and prevents the immune system collapse that makes AIDS fatal. Decreasing mortality trends have been observed across all racial and gender groups in countries where treatment became widely available. The drugs don’t cure HIV, but they can reduce the virus to undetectable levels, effectively turning what was once a death sentence into a manageable chronic condition.
Who Is Still Dying
Children remain disproportionately vulnerable. In 2024, approximately 75,000 children died from HIV-related causes, down from 240,000 in 2010. That improvement is real, but the gap between adult and pediatric progress is notable. Children are harder to diagnose, pediatric drug formulations have historically lagged behind adult versions, and many children with HIV were infected during pregnancy or breastfeeding in settings where maternal testing and prevention programs are inconsistent.
In the United States, where treatment access is comparatively strong, 4,496 people aged 13 and older died from HIV-related causes in 2023. The U.S. death rate is low relative to the global picture, but it still reflects persistent gaps in care, particularly among communities facing poverty, stigma, and limited healthcare access.
What Actually Kills People With AIDS
AIDS itself doesn’t directly cause death. It destroys the immune system, leaving the body unable to fight infections that a healthy person would easily survive. The single biggest killer among people with HIV/AIDS is tuberculosis. In 2023, 161,000 people died from HIV-associated TB, making it responsible for roughly one in four AIDS-related deaths globally. HIV dramatically increases susceptibility to TB, and the two diseases accelerate each other when left untreated.
Other respiratory infections also pose serious threats, including a fungal lung infection called pneumocystis pneumonia and common bacterial pneumonia. Both can become life-threatening in someone whose immune defenses have been hollowed out by the virus. Cryptococcal meningitis, a fungal infection of the brain, is another major killer, particularly in sub-Saharan Africa where access to both HIV treatment and antifungal drugs can be limited.
Why People Still Die Despite Available Treatment
The most frustrating aspect of modern AIDS mortality is that effective treatment exists. The drugs work. Yet 630,000 people still die each year, and the reasons are less about medicine than about the systems delivering it.
Late diagnosis is a major factor. Many people don’t learn they have HIV until their immune system is already severely damaged. By that point, even starting treatment may not be enough to prevent fatal infections. Research from UCSF found that roughly half of deaths among people newly starting treatment occurred soon after a clinic visit, suggesting that by the time patients entered care, critical health problems had already been missed.
Staying on treatment is its own challenge. Stigma keeps people from seeking care. Transportation to clinics is a barrier in rural areas. People who move for work, housing, or family reasons often fall out of the system entirely because clinics have no reliable way to share patient records or coordinate handoffs. Any break in treatment allows the virus to rebound, and repeated interruptions can lead to drug resistance, making HIV harder to control with standard medications. Spikes in viral load during treatment gaps also increase the risk of transmitting the virus to partners.
Mental health struggles, caregiving responsibilities, and economic instability all compound the problem. Treatment requires consistent daily medication, regular clinic visits, and lab monitoring. For someone juggling survival-level stressors, that consistency can be impossible to maintain.
The 2030 Global Target
A decade ago, the global community set a goal to reduce both new HIV infections and AIDS-related deaths by 90% from 2010 levels by the year 2030. Using 2010’s figure of 1.4 million deaths as the baseline, that target means getting annual deaths below 140,000. The current count of 630,000 means the world needs to cut deaths by more than three-quarters in the remaining years, a pace of decline far steeper than what’s been achieved so far.
Progress has been real but uneven. Countries with strong health infrastructure and political commitment have driven their death tolls down dramatically. But the regions carrying the heaviest burden, particularly parts of sub-Saharan Africa, still face enormous gaps in testing, treatment access, and the basic health services needed to keep people alive once they start therapy. Closing that gap in five years would require not just more funding, but fundamental improvements in how care reaches the most vulnerable populations.